| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 10/27/267:30 AM | $0.33 | $0.56GAAP | +69.7% | +143% | $260.4M | $286.0M | +9.8% | +58% | |
| Q2 '26 | 7/28/267:30 AM | $0.30 | $0.30GAAP | 0.0% | +30% | $226.7M | $243.6M | +7.5% | +55% | |
| Q1 '26 | 4/28/267:30 AM | $0.16 | $0.27GAAP | +68.8% | +145% | $205.6M | $214.3M | +4.2% | +56% | |
| Q4 '25 | 2/24/267:30 AM | $0.35 | $0.17GAAP | -51.4% | +242% | $200.9M | $202.1M | +0.6% | +65% | |
| Q3 '25 | 10/28/257:30 AM | $0.35 | $0.23GAAP | -34.3% | +228% | $166.8M | $180.9M | +8.4% | +61% | |
| Q2 '25 | 7/29/257:30 AM | $0.21 | $0.23GAAP | +9.5% | +483% | $145.2M | $156.8M | +8.0% | +44% | |
| Q1 '25 | 4/29/257:30 AM | $0.28 | $0.11GAAP | -60.7% | +144% | $131.7M | $137.8M | +4.6% | +73% |
GAAP = diluted EPS as filed with the SEC.